Follow
Savior Lifetec Corporation (SLC) is a specialty injectable company based in Chunan, Taiwan. There state of the art facilities are vertically integrated, capable of producing sterile API and finished dosage formulations. Savior Lifetec Corporation facilities comply with the highest quality standards, having passed inspections by authorities from the US, EU, and Japan. SLC also has dedicated state-of-the-art GLP compliant R&D centers for API research and pharmaceutical research.
SLC’s expertise in sterile crystallization and the aseptic processing of sterile powder serves as the foundation for product innovation.
Mission of Savior Lifetec Corporation
“Manufacturing quality products to meet the needs of patients worldwide while adding value to Savior employees, shareholders, and the Taiwan pharmaceutical industry in the creation of a healthier environment.”
History of SLC:
Vertical Integration Stage
2019- US ANDA Approval for Ertapenem
2018- UK ANDA Approval for Ertapenem
2016- US ANDA Approval for Meropenem
2015- Savior Lifetec Corporation (4167.TWO) is officially listed on TPEx
2014- Injection Plant(IP)in Tainan, Taiwan Passes US FDA cGMP Audit
2013- Injectable facility passes Spain AEMPS inspection
2013- Injectable facility passes Taiwan TFDA inspection
2012- Savior Lifetec Corporation (4167.TWO) registered on the Emerging Board
2011- Injectable plant at Tainan Science Park established
Founding Stage
2011- API facility passes US FDA inspection
2010- API facility passes UK MHRA inspection
2009- API facility passes Japan PMDA inspection
2007- First to register US DMF for Meropenem
2006- Branch site at Tainan Science Park established
2006- API facility passes Taiwan Ministry of Health inspection
2006- First to register US DMF for Imipenem-Cilastatin
2004- HQ site at Chunan Science Park established
